Slow Gait Speed as an Indicator of Overweight, Dynapenic Obesity and Sarcopenic Obesity in Elderly People in the Community
Launched by UNIVERSITY OF AMERICAS · May 13, 2024
Trial Information
Current as of July 25, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subjects over 60 years of age
- • Female and male
- • Self-sufficient in the instrumental activities of daily living
- • Subjects with or without drug consumption, capable of carrying out the activity of walking independently or dependent on technical aids.
- Exclusion Criteria:
- • Subjects with acute musculoskeletal injuries of the lower extremity.
About University Of Americas
The University of Americas is a leading academic institution dedicated to advancing medical research and clinical trials aimed at improving patient outcomes. With a robust framework for innovation and collaboration, the university leverages its interdisciplinary expertise to conduct high-quality, ethically sound studies across various therapeutic areas. Committed to fostering a culture of scientific inquiry, the University of Americas emphasizes the importance of translating research findings into practical applications, ultimately contributing to the advancement of healthcare and the well-being of communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Concepción, , Chile
Patients applied
Trial Officials
Karen Córdova-León, PT
Principal Investigator
Academic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported